Biogen Idec Inc. (BIIB) reported fourth quarter non-GAAP EPS of $4.09 after the bell Thursday, up from $2.34 last year. Analysts expected EPS of $3.78. Full year 2015 non-GAAP EPS is expected to be between $16.60 and $17.00. The consensus estimate is for EPS of $16.37. The stock is now up 25.97 on 168K shares.
Biogen Idec rose above Thursday's range going into the close and finished with a gain of 2.07 at $353.25.
For comments and feedback contact: editorial@rttnews.com
Business News
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.